Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,69 USD | -0,59% | -1,17% | -24,89% |
21/03 | VOR BIOPHARMA INC. : Stifel Nicolaus herhaalt koopadvies voor het aandeel | ZM |
21/03 | VOR BIOPHARMA INC. : Oppenheimer geeft koopadvies | ZM |
Omzet 2024 * | - | Omzet 2025 * | 1,43 mln. 1,34 mln. | Marktkapitalisatie | 115 mln. 108 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -102 mln. -95,4 mln. | Nettowinst (verlies) 2025 * | -115 mln. -108 mln. | EV/omzet 2024 * | - |
Nettoschuld 2024 * | 16,29 mln. 15,24 mln. | Nettoliquiditeiten 2025 * | 52,11 mln. 48,74 mln. | EV/omzet 2025 * | 44,2 x |
K/w-verhouding 2024 * |
-1,22
x | K/w-verhouding 2025 * |
-1,25
x | Werknemers | 168 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 98,83% |
1 dag | -0,59% | ||
1 week | -1,17% | ||
Lopende maand | -28,69% | ||
1 maand | -23,53% | ||
3 maanden | -27,78% | ||
6 maanden | -19,52% | ||
Lopend jaar | -24,89% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Bob Ang
CEO | Chief Executive Officer | 49 | 07-08-19 |
Nathan Jorgensen
DFI | Director of Finance/CFO | 47 | 01-05-20 |
Chief Tech/Sci/R&D Officer | 51 | 01-10-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
David Lubner
BRD | Director/Board Member | 60 | 30-07-20 |
Matt Patterson
CHM | Chairman | 52 | 20-10-20 |
Bob Ang
CEO | Chief Executive Officer | 49 | 07-08-19 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.01% | 0 M€ | 0,00% | - | |
0.00% | 34 M€ | +2,14% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 1,69 | -0,59% | 154 391 |
25-04-24 | 1,7 | -2,30% | 181 018 |
24-04-24 | 1,74 | -7,45% | 287 032 |
23-04-24 | 1,88 | +3,30% | 209 685 |
22-04-24 | 1,82 | +6,43% | 232 177 |
uitgestelde koers Nasdaq, 26 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-24,89% | 115 mln. | |
+1,51% | 42,75 mld. | |
+49,22% | 41,61 mld. | |
+8,57% | 41,34 mld. | |
-12,36% | 26,59 mld. | |
+8,92% | 25,49 mld. | |
-25,13% | 18,12 mld. | |
+29,17% | 12,24 mld. | |
-3,12% | 11,76 mld. | |
+6,35% | 11 mld. |